重型新型冠状病毒肺炎与重型社区获得性肺炎临床特征对比分析
本研究回顾性对比了武汉第三医院2020年1月1日至3月31日收治的116例重型COVID-19患者与上海市第一人民医院2010年1月1日至2017年12月31日收治的135例重型社区获得性肺炎(sCAP)患者的临床资料。结果显示,重型COVID-19与sCAP的28天死亡率分别为50.9%(59/116)和37.0%(50/135);重型COVID-19中PaO2/FiO2≤250 mmHg者占62.1%(72/116),显著高于sCAP的34.8%(47/135),P<0.01;多肺叶浸润比例为94.0%(109/116)vs 40.0%(54/135),P<0.01;需要机械通气的比例反而更低,为45.7%(53/116)vs 60.0%(81/135),P<0.05。多因素分析显示,重型COVID-19患者28天死亡的独立危险因素为需要机械通气、NLR>10、TBil>10 μmol/L、LDH>250 U/L;sCAP患者28天死亡的独立危险因素为BUN>7.14 mmol/L、ALB<30 g/L。作者认为,重型COVID-19对肺氧合功能、炎症级联反应和肝功能的影响更大,而sCAP对肾功能和营养状况的影响更大。
要点
- 本研究队列中,重型COVID-19的28天死亡率为50.9%(59/116),sCAP为37.0%(50/135),前者更高
- 重型COVID-19中PaO2/FiO2≤250 mmHg者占62.1%(72/116),显著高于sCAP的34.8%(47/135),P<0.01
- 重型COVID-19多肺叶浸润占94.0%(109/116),显著高于sCAP的40.0%(54/135),P<0.01;但需要机械通气者占45.7%(53/116),显著低于sCAP的60.0%(81/135),P<0.05
- 重型COVID-19患者28天死亡的危险因素为需要机械通气、NLR>10、TBil>10 μmol/L、LDH>250 U/L(Logistic回归分析)
- sCAP患者28天死亡的危险因素为BUN>7.14 mmol/L、ALB<30 g/L(Logistic回归分析)
适用人群与场景
- 纳入标准:符合美国感染病学会/美国胸科学会(IDSA/ATS)重型肺炎诊断标准的重型COVID-19患者(武汉第三医院重症医学科,2020年1月1日至3月31日,116例)与sCAP患者(上海市第一人民医院重症医学科,2010年1月1日至2017年12月31日,135例)
- 场景:ICU住院患者
诊断标准与关键阈值
- 重型肺炎诊断标准:美国感染病学会/美国胸科学会(IDSA/ATS)重型肺炎诊断标准
- 氧合分层阈值:PaO2/FiO2≤250 mmHg(1 mmHg≈0.133 kPa),重型COVID-19为62.1%(72/116)vs sCAP为34.8%(47/135),P<0.01
- 影像:多肺叶浸润,重型COVID-19为94.0%(109/116)vs sCAP为40.0%(54/135),P<0.01
研究设计与关键结果
- 研究类型:回顾性对比分析;样本量:sCOVID-19 116例、sCAP 135例
- 28天死亡率:sCOVID-19 50.9%(59/116)vs sCAP 37.0%(50/135)
- PaO2/FiO2≤250 mmHg比例:sCOVID-19 62.1%(72/116)vs sCAP 34.8%(47/135),P<0.01
- 多肺叶浸润比例:sCOVID-19 94.0%(109/116)vs sCAP 40.0%(54/135),P<0.01
- 需要机械通气比例:sCOVID-19 45.7%(53/116)vs sCAP 60.0%(81/135),P<0.05
- sCOVID-19死亡组与存活组间PaO2/FiO2、WBC、NEU、NEU%、NLR、TBil、BUN、ALB、Ca2+、PT、D-二聚体、CRP等指标有显著差异;死亡组接受机械通气、丙种球蛋白、激素及液体复苏的比例高于存活组
- sCOVID-19的Logistic回归:需要机械通气、NLR>10、TBil>10 μmol/L、LDH>250 U/L为28天死亡的危险因素
- sCAP死亡组与存活组间年龄、BUN、ALB、血糖(GLU)、Ca2+、D-二聚体有显著差异,治疗方面无显著差异;Logistic回归显示BUN>7.14 mmol/L、ALB<30 g/L为28天死亡的危险因素
证据类型、等级与局限
- 证据类型:回顾性对比分析
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,重型COVID-19患者氧合状况与症状比sCAP患者更差,可能与肺部病变累及比例高有关
- 作者认为,两种疾病对肾功能、营养状态和凝血功能的影响相似,但影响生存的危险因素仍有差异
- 作者认为,重型COVID-19对肺氧合功能、炎症级联反应和肝功能的影响更大,而sCAP对肾功能和营养状态的影响更大
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare and analyze the clinical features of patients with severe coronavirus disease 2019 (sCOVID-19) and severe community acquired pneumonia (sCAP) who meet the diagnostic criteria for severe pneumonia of the Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS).
METHODS: A retrospective comparative analysis of the clinical records of 116 patients with sCOVID-19 admitted to the department of critical care medicine of Wuhan Third Hospital from January 1, 2020 to March 31, 2020 and 135 patients with sCAP admitted to the department of critical care medicine of Shanghai First People's Hospital from January 1, 2010 to December 31, 2017 was conducted. The basic information, diagnosis and comorbidities, laboratory data, etiology and imaging results, treatment, prognosis and outcome of the patients were collected. The differences in clinical data between sCOVID-19 and sCAP patients were compared, and the risk factors of death were analyzed.
RESULTS: The 28-day mortality of sCOVID-19 and sCAP patients were 50.9% (59/116) and 37.0% (50/135), respectively. The proportion of arterial partial pressure of oxygen/fraction of inspired oxygen (PaO2/FiO2) ≤ 250 mmHg (1 mmHg ≈ 0.133 kPa) in sCOVID-19 patients was significantly higher than that of sCAP [62.1% (72/116) vs. 34.8% (47/135), P < 0.01]. The possible reason was that the proportion of multiple lung lobe infiltration in sCOVID-19 was significantly higher than that caused by sCAP [94.0% (109/116) vs. 40.0% (54/135), P < 0.01], but the proportion of sCOVID-19 patients requiring mechanical ventilation was significantly lower than that of sCAP [45.7% (53/116) vs. 60.0% (81/135), P < 0.05]. Further analysis of clinical indicators related to patient death found that for sCOVID-19 patients PaO2/FiO2, white blood cell count (WBC), neutrophils (NEU), neutrophil percentage (NEU%), neutrophil/lymphocyte ratio (NLR), total bilirubin (TBil), blood urea nitrogen (BUN), albumin (ALB), Ca2+, prothrombin time (PT), D-dimer, C-reactive protein (CRP) and other indicators were significantly different between the death group and the survival group, in addition, the proportion of receiving mechanical ventilation, gamma globulin, steroid hormones and fluid resuscitation in death group were higher than survival group. Logistic regression analysis showed that the need for mechanical ventilation, NLR > 10, TBil > 10 μmol/L, lactate dehydrogenase (LDH) > 250 U/L were risk factors for death at 28 days. For sCAP patients, there were significant differences in age, BUN, ALB, blood glucose (GLU), Ca2+ and D-dimer between the death group and the survival group, but there was no significant difference in treatment. Logistic regression analysis showed that BUN > 7.14 mmol/L and ALB < 30 g/L were risk factors for 28-day death of sCAP patients.
CONCLUSIONS: The sCOVID-19 patients in this cohort have worse oxygen condition and symptoms than sCAP patients, which may be due to the high proportion of lesions involving the lungs. The indicators of the difference between the death group and the survival group were similar in sCOVID-19 and sCAP patients. It is suggested that the two diseases have similar effects on renal function, nutritional status and coagulation function. But there were still differences in risk factors affecting survival. It may be that sCOVID-19 has a greater impact on lung oxygenation function, inflammatory cascade response, and liver function, while sCAP has a greater impact on renal function and nutritional status.
参考来源
- Teng X, Xie Y, Chen D, et al. [Comparative analysis of clinical features between severe coronavirus disease 2019 and severe community acquired pneumonia]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35728849. doi:10.3760/cma.j.cn121430-20211013-01477
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。